Dr Reddys Laboratories (RDY) Notes Payables (2009 - 2026)
Dr Reddys Laboratories' Notes Payables came in at $609.34 million for the quarter ended Jun 30, 2026, up 35.9% from $448.47 million a year earlier but down 5.8% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Notes Payables (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Notes Payables was $630 million, up 41.6% from the prior year.
- Notes Payables has increased in each of the last three years, with a five-year compound annual growth rate of 14.8% (years ended Mar 2021 to Mar 2026).
- Going back by year, Notes Payables was $445 million in the year ended Mar 31, 2025 (+190.8%), $153 million in the year ended Mar 31, 2024 (+70.0%), $90 million in the year ended Mar 31, 2023 (-74.8%) and $357 million in the year ended Mar 31, 2022 (+13.0%).
- The five-year range for quarterly Notes Payables is $70.73 million (the quarter ended Sep 30, 2023) to $646.89 million (the quarter ended Mar 31, 2026).
- Year-over-year, Notes Payables has increased for three consecutive quarters, with growth averaging 144.5% over the last eight quarters.
- The fastest year-over-year change in Notes Payables over five years came in the quarter ended Sep 30, 2024 (growth of 574.8%), and the weakest in the quarter ended Mar 31, 2023 (a decline of 75.0%).
- Business Quant data shows RDY's Notes Payables at $646.89 million (quarter ended Mar 31, 2026), $564.69 million (quarter ended Dec 31, 2025) and $471.83 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 609.34 Mn |
| Mar 31, 2026 | 646.89 Mn |
| Dec 31, 2025 | 564.69 Mn |
| Sep 30, 2025 | 471.83 Mn |
| Jun 30, 2025 | 448.47 Mn |
| Mar 31, 2025 | 439.34 Mn |
| Dec 31, 2024 | 502.17 Mn |
| Sep 30, 2024 | 477.29 Mn |
| Jun 30, 2024 | 277.70 Mn |
| Mar 31, 2024 | 153.20 Mn |
| Dec 31, 2023 | 148.24 Mn |
| Sep 30, 2023 | 70.73 Mn |
| Jun 30, 2023 | 78.73 Mn |
| Mar 31, 2023 | 89.90 Mn |
| Dec 31, 2022 | 139.68 Mn |
| Sep 30, 2022 | 135.09 Mn |
| Jun 30, 2022 | 232.15 Mn |
| Mar 31, 2022 | 360.17 Mn |
| Dec 31, 2021 | 284.70 Mn |
| Sep 30, 2021 | 315.54 Mn |
API Access
Dr Reddys Laboratories Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();